COMPANY
Plex Pharmaceuticals, Inc.
NIH awards 12
- NIH award 5R44EY027236-04 FY2021: $648,986 awarded for that fiscal year; activity R44 (SBIR); PI REMACLE, ALBERT; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Advancing CAP4196 into in vivo Proof source ↗
- NIH award 5R43EY031609-02 FY2021: $149,295 awarded for that fiscal year; activity R43 (SBIR); PI THOTA, SAMBAIAH; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Re-purposing the small-molecule drug, source ↗
- NIH award 5R43AI145617-02 FY2021: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI REMACLE, ALBERT; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Discovery and Development of Broad-sp source ↗
- NIH award 2R44EY027236-03 FY2020: $662,896 awarded for that fiscal year; activity R44 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Advancing CAP4196 into in vivo Proo source ↗
- NIH award 1R43EY031609-01 FY2020: $149,295 awarded for that fiscal year; activity R43 (SBIR); PI SINHA, SANTOSH C.; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Re-purposing the small-molecule dru source ↗
- NIH award 1R43AI145617-01A1 FY2020: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Discovery and Development of Broa source ↗
- NIH award 5R43EY027236-02 FY2017: $136,774 awarded for that fiscal year; activity R43 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Small molecule activators of alpha- source ↗
- NIH award 1R43EY027236-01 FY2016: $162,399 awarded for that fiscal year; activity R43 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Small molecule activators of alpha- source ↗
- NIH award 5R43AI114084-02 FY2015: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Development of Flavivirus Antiviral source ↗
- NIH award 1R43AI114084-01 FY2014: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Development of Flavivirus Antiviral source ↗
- NIH award 1R43GM090383-01A1 FY2010: $279,068 awarded for that fiscal year; activity R43 (SBIR); PI PRASAD, SRIDHAR G; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Selective and dual-acting Hsp90 a source ↗
- NIH award 1R43DK088457-01 FY2010: $201,930 awarded for that fiscal year; activity R43 (SBIR); PI STEBBINS, JEFFREY WILLIAM; recipient as written: PLEX PHARMACEUTICALS, INC., SAN DIEGO, CA. Discovery and Development o source ↗